Literature DB >> 1900874

Ligation of membrane Ig leads to calcium-mediated phosphorylation of the proto-oncogene product, Ets-1.

C L Fisher1, J Ghysdael, J C Cambier.   

Abstract

Recent studies have demonstrated that the nuclear protein, Ets-1, which is preferentially expressed in lymphocytes, binds to the long terminal repeat of Moloney murine sarcoma virus and HTLV-1 and regulates gene expression. The association of Ets-1 with DNA has been shown to be lost when the protein is phosphorylated. Thus, Ets-1 may regulate gene expression in lymphocytes and this activity may be determined by its phosphorylation state. To address the possibility that Ets-1 activity may be altered by membrane (m) Ig-mediated signal transduction, we analyzed the effect of mIgM and mIgD ligation on the phosphorylation state of Ets-1. Monoclonal anti-IgM or anti-IgD antibody stimulation of normal mouse B cells led to increased phosphorylation of Ets-1 within 2 min. This response was absolutely dependent on calcium mobilization and could be induced by elevation of intracellular free calcium using the calcium ionophore, ionomycin. Calcium release from intracellular stores was sufficient to mediate the phosphorylation of Ets-1. Treatment of resting B cells with IL-4, TGF beta-1, IFN-gamma, anti-class I, or anti-class II antibodies did not induce Ets-1 phosphorylation. In summary, calcium mobilization from intracellular stores after mIgM or mIgD ligation provides a necessary and sufficient signal for activation of Ets-1 phosphorylation. This phosphorylation event may act in the alteration of gene expression during B cell activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900874

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition.

Authors:  D O Cowley; B J Graves
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

2.  An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.

Authors:  J Hagman; R Grosschedl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

3.  Increase in the intracellular free calcium concentration is not an obligatory early event in lipopeptide-induced B-cell activation.

Authors:  S Hauschildt; A Lückhoff; J Langhorne; K H Wiesmüller; G Jung; W Bessler; J C Cambier
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

4.  Calcium regulation of GM-CSF by calmodulin-dependent kinase II phosphorylation of Ets1.

Authors:  Hebin Liu; Thomas Grundström
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

Review 5.  Ca2+-signaling, alternative splicing and endoplasmic reticulum stress responses.

Authors:  Joachim Krebs; Jody Groenendyk; Marek Michalak
Journal:  Neurochem Res       Date:  2011-03-02       Impact factor: 3.996

6.  B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events.

Authors:  S N Liossis; B Kovacs; G Dennis; G M Kammer; G C Tsokos
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

Review 7.  Review of Ets1 structure, function, and roles in immunity.

Authors:  Lee Ann Garrett-Sinha
Journal:  Cell Mol Life Sci       Date:  2013-01-05       Impact factor: 9.261

8.  ERP, a new member of the ets transcription factor/oncoprotein family: cloning, characterization, and differential expression during B-lymphocyte development.

Authors:  M Lopez; P Oettgen; Y Akbarali; U Dendorfer; T A Libermann
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

9.  IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function.

Authors:  P A Grant; C B Thompson; S Pettersson
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

10.  Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes.

Authors:  M A Valentine; A J Czernik; N Rachie; H Hidaka; C L Fisher; J C Cambier; K Bomsztyk
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.